Method for preparing oat husks for xylan production

Details for Australian Patent Application No. 2005263595 (hide)

Owner Dow Global Technologies Inc.

Inventors Saake, Bodo; Puls, Jurgen; Kahlke, Dirk

Agent Davies Collison Cave

Pub. Number AU-B-2005263595

PCT Pub. Number WO2006/008136

Priority 10 2004 034 849.9 19.07.04 DE

Filing date 18 July 2005

Wipo publication date 26 January 2006

Acceptance publication date 24 March 2011

International Classifications

C08B 37/00 (2006.01) Preparation of polysaccharides not provided for in

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/008136 Priority application(s): WO2006/008136

17 January 2008 Alteration of Name

  The name of the applicant has been altered to Dow Wolff Cellulosics GmbH; Peter Kolln KGaA

14 August 2008 Assignment before Grant

  Dow Wolff Cellulosics GmbH; Peter Kolln KGaA The application has been assigned to Dow Wolff Cellulosics GmbH

18 June 2009 Assignment before Grant

  Dow Wolff Cellulosics GmbH The application has been assigned to Dow Global Technologies, Inc.

16 July 2009 Corrigenda

  Assignments Before Grant, Section 113 - 2005 Under the name Dow Wolff Cellulosics GmbH, Application No. 2005263595, under INID (71) correct the name to read Dow Global Technologies Inc.

24 March 2011 Application Accepted

  Published as AU-B-2005263595

21 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005263596-Reinforcing element for a lower area of a front bumper, and correspondingly equipped bumper for a motor vehicle

2005263592-Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof